Progyny (NASDAQ:PGNY) Stock Price Up 3.3% – Time to Buy?

Shares of Progyny, Inc. (NASDAQ:PGNY) shot up 3.3% during trading on Monday . The stock traded as high as $22.66 and last traded at $22.62. 145,917 shares were traded during mid-day trading, a decline of 91% from the average session volume of 1,690,619 shares. The stock had previously closed at $21.90.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. JPMorgan Chase & Co. boosted their price target on shares of Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a report on Tuesday, January 28th. Canaccord Genuity Group boosted their target price on Progyny from $17.00 to $23.00 and gave the stock a “hold” rating in a research note on Friday, February 28th. BTIG Research raised Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price target for the company in a research report on Monday. Finally, Bank of America boosted their price objective on Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. Eight analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Progyny presently has an average rating of “Hold” and a consensus price target of $23.64.

Progyny Trading Up 2.9 %

The stock has a market cap of $1.92 billion, a PE ratio of 38.75, a PEG ratio of 2.39 and a beta of 1.41. The business has a 50-day moving average price of $22.06 and a 200 day moving average price of $18.50.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Signaturefd LLC increased its position in shares of Progyny by 1,355.0% during the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock valued at $25,000 after buying an additional 1,355 shares during the period. GAMMA Investing LLC boosted its holdings in Progyny by 341.4% in the 4th quarter. GAMMA Investing LLC now owns 1,611 shares of the company’s stock valued at $28,000 after purchasing an additional 1,246 shares during the period. Nisa Investment Advisors LLC grew its position in shares of Progyny by 108.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company’s stock valued at $51,000 after purchasing an additional 1,526 shares in the last quarter. Caitlin John LLC grew its position in Progyny by 2,974.8% during the fourth quarter. Caitlin John LLC now owns 3,290 shares of the company’s stock worth $57,000 after buying an additional 3,183 shares in the last quarter. Finally, Natixis bought a new position in shares of Progyny in the fourth quarter worth approximately $69,000. 94.93% of the stock is owned by institutional investors.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.